CD163 and neoplasm: Regarding tumor necrosis, ANOVA analysis revealed variations in FKBP51s TME-TAMs and CD163 and CD163/FKBP51s PB-TAMs in three patient groups categorized according to the NS (0+1, 2,3; Supplementary Fig. S14).